Next-Generation Sequencing (NGS) of the entire tumor “mutanome”, i.e., mapping of all the mutations in the tumors and prediction of MHC molecule–binding neoepitopes revealed that tumor mutation burden and T cell infiltrations correlate with patient survival across various cancer types [95,99]. The gene discussed is HLA-C; the disease is cancer.